Reuters logo
BRIEF-Kalytera Therapeutics names Robert Farrell CEO
2017年10月11日 / 凌晨12点52分 / 10 天前

BRIEF-Kalytera Therapeutics names Robert Farrell CEO

Oct 10 (Reuters) - Kalytera Therapeutics Inc-

* Kalytera Therapeutics, Inc. announces Robert Farrell, J.D. as CEO; additional board and management changes

* Kalytera Therapeutics- ‍Pini Ben-Elazar, who served as a member of company’s board since March 2017, has submitted his resignation from board​

* Company has accepted resignation of Mr. David Bassa, who served as company’s chief operating officer​ Source text for Eikon: [ID: nBw42Dzdha] Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below